Company
PainChek Limited
Headquarters: Sydney, NSW, Australia
CEO: Mr. Philip Daffas B.Sc., M.B.A., BSc, Dip EENG, MBA, GAICD
Market Cap
A$58.9 Million
AUD as of Jan. 1, 2024
US$40.1 Million
PainChek Limited Categories
Australia Healthcare Health Information ServicesAustralia Healthcare Australia Health Information Services
Top Competitors by Market Capitalization
Industry: Health Information Services
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $34.86 B |
| Veeva Systems Inc. | $29.97 B |
| M3, Inc. | $11.24 B |
| Change Healthcare Inc. | $9.03 B |
| Signify Health, Inc. | $8.38 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
PainChek Limited has the following listings and related stock indices.
Stock: ASX: PCK wb_incandescent